CDC Pushed for COVID-19 Boosters Without Clinical Trials

Zachary Stieber

The U.S. Centers for Disease Control and Prevention (CDC) pressured U.S. regulators to clear COVID-19 boosters without clinical trial data, according to newly released emails. CDC officials relayed to counterparts at the Food and Drug Administration (FDA) in early August 2021 that they wanted authorization for Moderna and Pfizer boosters as data began showing that the vaccines weren’t working as well as initially promoted. The conversation took place on a call that was described by Dr. Phil Krause, a top FDA official, to several other FDA workers. “Take a deep breath before reading this next paragraph. On that call, the CDC evidently stated that they will assemble all the data they are aware of on third dosing in this setting and send it to us in the hope that we will (very soon) authorize the third dose for immunocompromised as part of the EUA,” Krause wrote in the Aug. 5, 2021, email (pdf). EUA stands for emergency use authorization..........To Read More.....

The Updated mRNA COVID Boosters Are a Bust, Two New Studies Show By Debra Heine - The new, heavily promoted mRNA booster shots from Pfizer and Moderna are not all they’re cracked up to be, according to two new preprint studies.  The boosters perform no better against Omicron than the fourth jab with the original formulation,” a new study from scientists at Columbia University in New York City found. The updated Covid-19 booster shots have been advertised as “bivalent,” meaning they target the original coronavirus strain as well as the Omicron BA.4/BA.5 subvariants.  However, the Columbia paper found that the newer Omicron variants easily evade both types of boosters, Alex Berenson reported on Substack................